Penn Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
Penn Capital Management's MIRM Position: Q3 2026 in Review
Penn Capital Management reduced its Mirum Pharmaceuticals (MIRM) stake by 4.2% in Q3 2026, selling an estimated $1.32M and leaving 286,281 shares worth $24.5M. The position accounts for 1.78% of the portfolio, ranked #5.
Penn Capital Management first reported a position in MIRM in Q2 2023 and has held it in 14 quarters since. The position peaked at $35.1M in Q2 2026. 314 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.
- Penn Capital Management held 286,281 shares of Mirum Pharmaceuticals worth $24.5M as of Q3 2026.
- Penn Capital Management sold 12,633 Mirum Pharmaceuticals shares in Q3 2026, an estimated $1.32M.
- Mirum Pharmaceuticals made up 1.78% of Penn Capital Management's portfolio in Q3 2026, its #5 holding.
- Penn Capital Management first reported a position in Mirum Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
- Penn Capital Management's Mirum Pharmaceuticals position peaked at $35.1M in Q2 2026.
- 314 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.
Based on Penn Capital Management's 13F filing for Q3 2026, filed 4 Nov 2026.